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AJH 2004; 17:994–1001There are gender-associated differences in blood pressure
(BP) in humans, with men having higher BP than age-
matched pre-menopausal women and being at greater risk
for cardiovascular and renal diseases. The mechanisms
responsible for the gender differences in BP control and
regulation are not clear, although there is some evidence
that interactions between sex hormones and the kidneys
could play a role. However, the response to salt in pre- and
post-menopausal women, and in particular the influence of
exogenous and endogenous female sex hormones on renal
hemodynamics and tubular segmental sodium handling,
have been poorly investigated. Recently we have shown
that both endogenous and exogenous female sex hormones
markedly influence the systemic and renal hemodynamic
response to salt. We have found that BP in young normo-
tensive women, regardless of oral contraceptive use, is
rather insensitive to salt. However, the renal hemodynamic
and the tubular responses to salt vary significantly duringSupported by the Fonds National Suisse de la Recherche Scientifique
0895-7061/04/$30.00
doi:10.1016/j.amjhyper.2004.08.009the normal menstrual cycle and with the administration of
oral contraceptives. Furthermore, after the menopause, BP
tends to become salt sensitive, a pattern that could be due
to aging as well as to the modification of the sex hormone
profile. These observations provide new insights pertain-
ing to potential mechanisms explaining the lower inci-
dence of cardiovascular disease and progression of renal
disease in pre-menopausal women (which tend to disap-
pear with the menopause); these observations also empha-
size the importance of considering more carefully the
phase of the menstrual cycle whenever conducting phys-
iologic studies in women and enrolling women in clinical
studies. Finally, increased salt sensitivity in menopausal
women strongly encourages the use of diuretics. Am J
Hypertens 2004;17:994–1001 © 2004 American Journal
of Hypertension, Ltd.
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endogenous lithium, renal hemodynamics.Gender-associated differences in blood pressure (BP)have been observed in animals as well as in hu-mans.1–3 Thus, in humans, men have higher BP
levels than women until the age of 60 to 70 years, when BP
becomes progressively more comparable in both men and
women. Hence, men are also at greater risk for developing
cardiovascular and renal complications.1,2 The mechanisms
responsible for these gender differences in BP are not well
understood, but several hypotheses have been proposed sug-
gesting a role of androgens and female sex hormones.3
The kidneys play a major role in the regulation of BP.
According to the hypothesis of Guyton et al, a decrease in
renal sodium excretion or a rightward shift of the pres-
sure–natriuresis relationship can lead to a long-term in-
crease in BP and the development of hypertension.4 In
accordance with this hypothesis, Reckelhoff et al have
reported that the pressure–natriuresis curve is blunted in
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handling of sodium and thereby contribute to the gender-
associated differences observed in animal models and in
humans is also a subject of controversy. In this review, we
discuss the potential links among female sex hormone
status, salt balance, and renal function and their possible
influence on BP regulation. We also present recent results
indicating that both endogenous and exogenous female sex
hormones have important effects on the systemic and renal
responses to changes in sodium intake in young, healthy,
normotensive women, regardless of whether they are using
oral contraceptives (OC), and in menopausal women who
are not receiving hormonal replacement therapy.
Gender Difference in BP
Regulation and Pressure–
Natriuresis in Animal Models
As mentioned earlier here, there is good evidence to sup-
port the role of androgens in mediating the increased BP in
male rats and perhaps in elderly female rats.3 However,
there is also some evidence suggesting that female sex
hormones may actually protect against a salt-induced in-
crease in BP, possibly by augmenting the renal excretion
of sodium. Thus, when Dahl salt-sensitive (DS) rats re-
ceive a high-sodium diet, female rats become less hyper-
tensive than male rats.10 In this animal model,
gonadectomy results in an accelerated development of
salt-sensitive hypertension in females.10 Whether gonad-
ectomy affects BP in the male DS rats is more controver-
sial. Indeed, results obtained so far are inconsistent.
Rowland and Fregly found that gonadectomy reduces BP
in male DS rats,11 but this observation was not reported by
others.10 The increase in salt sensitivity observed after
ovariectomy is actually associated with a blunted pres-
sure–natriuresis relationship. Interestingly, reversal of the
diet to a low salt intake reverses the hypertension in intact
male and female DS rats, but this was not the case in
ovariectomized female DS rats, suggesting that female sex
hormones act to suppress sodium dependent as well as
sodium independent increases in BP.12 A greater rise in
BP has also been reported in spontaneously hypertensive
female rats after ovariectomy.13,14 Dietary phytoestrogens
have been found to protect ovariectomized female SHR
from dietary salt-sensitive hypertension.15 The sympa-
thetic nervous system seems to play an important role in
mediating this effect, as ganglionic blockade reduces the
sodium-induced rises in arterial pressure.15
Of note, female sex hormones may affect not only renal
sodium excretion but perhaps also sodium intake per se.
Indeed, in many mammals, the spontaneous free sodium
intake appears to be greater in females than in males of the
same species. In this respect, estradiol has recently been
found to modulate the sodium intake of hypertensive (ie,
SHR) and normotensive (ie, Wistar-Kyoto) female rats,
and is positively correlated with sodium intake in bothstrains, with the hypertensive rats consuming more sodium
than the normotensive rats.16 This remarkable gender-
related difference in sodium ingestion may originate phy-
logenetically in the need to preserve sodium losses during
pregnancy. Taken together, these experimental findings
suggest that female sex hormones indeed modulate sodium
balance in animals and may therefore contribute to the
regulation of BP.
Gender Differences in the Activity
of the Renin-Angiotensin System
The renin-angiotensin system is one of the key hormonal
systems regulating BP and modulating the pressure–natriure-
sis relationship. Several studies have reported gender differ-
ences in various components of the renin-angiotensin cascade
that could partially explain the gender differences in BP.17
Thus, in a normotensive population, plasma renin activity
(PRA) has been reported to be higher in men than in women
regardless of age and ethnic heritage.18 Exogenous female
sex hormones administered for oral contraception have also
been shown to stimulate angiotensinogen production, which
may lead to a increase in BP in some women.19 Other studies
have found that PRA is higher in post-menopausal than in
pre-menopausal women, although PRA remains higher in
men than in women of the same age.17 In animals significant
differences have also been observed between males and fe-
males. The administration of testosterone to ovariectomized
female rats increases PRA, and PRA is lower in males after
castration.20,21 Finally, in Sprague-Dawley rats, a linear cor-
relation between the levels of testosterone and plasma renin
activity levels has been reported,3,17 suggesting that testos-
terone stimulates the renin-angiotensin system. In accordance
with this observation, several studies have found that andro-
gens like oestrogens enhance renal angiotensinogen
mRNA.20,22
There is also some evidence that the response to a
stimulation of the renin-angiotensin system differs in men
and women. Thus, Miller et al have compared the renal
hemodynamic response to the infusion of exogenous an-
giotensin II in young normotensive pre-menopausal
women and in age-matched men and found striking dif-
ferences.23 Both groups exhibited an increase in BP and a
decrease in effective renal plasma flow (ERPF) with an-
giotensin II, but only men maintained their glomerular
filtration rate (GFR) resulting in an increased filtration
fraction. In women, the administration of angiotensin II
decreased GFR, leading to a reduction in filtration frac-
tion. This has been interpreted as a lesser increase in
intraglomerular pressure in women, an observation which
may play a role in renal disease progression. The incidence
of end-stage renal disease is indeed lower in women than
in men even after adjustment for age and race.24 Further-
more, the rate of progression to end-stage renal disease is
often slower in women than in men, independently of BP
25or serum cholesterol levels.
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and the BP Response to Salt
Few clinical studies have assessed specifically the effect of
gender on the BP response to salt. There are some sugges-
tions that the hormonal status modulates this response and
that hypertensive females are more salt sensitive than males,
but this has not been confirmed by all investigators.1,26 The
relationship between salt intake and BP tends to become
more marked in post-menopausal than in pre-menopausal
women, but this observation may be attributed to aging. Little
attention has also been given to the changes in BP occurring
in young women during the normal menstrual cycle, and the
few investigations performed so far have led to rather incon-
sistent results. Indeed, the BP has been shown to be higher in
the luteal phase or at the onset of menstruation in some
studies27–29 or significantly decreased in the mid-luteal phase
of the cycle both in normotensive30,31 and hypertensive
women32 or even unchanged across the entire cycle.33 Most
of these studies were based on office or home BP and with an
uncontrolled sodium intake. More recently a prospective trial
suggested that the ambulatory systolic BP is higher through-
out the menstrual cycle in women taking OC than in women
who do not, but no change in ambulatory pressure was found
across the menstrual cycle.34 Because little is known about
the effects of female sex hormones on the BP response to salt,
we have recently performed a series of studies to assess
prospectively the influence of exogenous and endogenous
female sex hormones on the systemic hemodynamic response
to changes in sodium intake in young healthy normotensive
women and in menopausal women.35–38
In brief, 35 young normotensive white females who had
regular menstruation and were not using OC were ran-
domly assigned to be studied during the follicular (n 17)
and the luteal (n  18) phases of the menstrual cycle. In
addition, 27 young white healthy women who were using
OC (monophasic combination of 30 g ethinylestradiol
and 150 g desogestrel for 6 months) and 12 meno-
pausal women not receiving hormonal replacement ther-
Table 1. Characteristics of the study groups
Follicular
(n  17)
Age (y) 27.6
Range 21–40
Family history of hypertension 7/17
BMI (kg/m2) 21  0.6
Premenstrual symptoms 8/17
Cycle length (days) 27.6  0.5
Blood pressure (mm Hg) 108.8/74.9
Heart rate (beats/min) 77.3  3
Serum creatinine (mol/L) 83.1  2
UNaV (mol/min) 197  16
BMI  body mass index; UNaV  urinary sodium excretion.
Data are mean  SEM.
* P  .05 v other phases.apy were investigated using a comparable protocol.Characteristics of these subjects are presented in Table 1.
All subjects were randomized to receive a diet low in
sodium (40 mmol Na/day) and a diet high in sodium
(250 mmol Na/day) for a 7-day period for 2 consecutive
months. At the end of each 7-day diet period, 24-h ambu-
latory BP as well as renal hemodynamics and renal sodium
handling and an hormonal profile were measured.35–39
As shown in Fig. 1, we found that the BP and heart rate
response to salt is comparable in the luteal and in the
follicular phases of the normal menstrual cycle. In both
phases of the cycle, the pressure–natriuresis relationship is
steep, suggesting that these women are essentially insen-
sitive to salt. The administration of OC does not modify
the pressure–natriuresis relationship, suggesting little if
any effect of exogenous female sex hormones on the BP
response to salt. In contrast, the pressure–natriuresis curve
of menopausal women is significantly shifted to the right,
indicating that BP becomes salt sensitive after the meno-
pause as suggested previously by Weinberger et al.40
Unfortunately, our study does not allow any conclusion
Luteal
(n  18)
Contraceptive
(n  27)
Menopause
(n  12)
29.1 26 49*
20–39 20–40 43–50
9/18 14/27 9/12
21.4  0.9 20.8  0.5 25.3*  1.2
12/18
28.6  0.6
110.3/76.1 108/72 117.8*/80.5*
76.1  3 82  2 80.9  2.5
83.2  2 76  2 87  2
182  11 168  12 194  18
FIG. 1. Pressure–natriuresis relationship in normotensive women
during the normal menstrual cycle, during use of oral contracep-
tives, and after menopause. All women received randomly a diet low
in sodium (40mmol Na/day) and high in sodium (250mmol Na/day)
for 1 week. Blood pressure was measured over 24 h using ambula-
tory blood pressure monitoring.
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tivity that develops after the menopause and, particularly,
whether it is due to aging only or to the modification of the
hormonal profile. In humans, some studies have suggested
that the BP increase after the onset of menopause is linked
to a reduced synthesis of estradiol or to an imbalance
between androgens and female sex hormones, but this
remains to be demonstrated.3 Nevertheless, our results
may provide new clues to explain why the incidence of
hypertension clearly increases in post-menopausal fe-
males, exceeding that in age-matched men.41 Indeed, if
sodium intake is not reduced, the increased responsiveness
to sodium at the menopause may contribute to increase BP
and to favour the development of hypertension. Of note,
the menopause is often associated with a weight gain, and
the prevalence of obesity is higher in post-menopausal
women than in age-matched men.42 This would indicate
that sodium intake is certainly not reduced in menopausal
women. We have also reported previously that the increase
in body weight occurring at the time of the menopause is
actually associated with a significant increase in ambula-
tory BP.43
Female Sex Hormones
and the Renal Hemodynamic
Response to Salt
The literature is also conflicting concerning the possible
changes in renal hemodynamics occurring during the normal
menstrual cycle.30,31,44–48 Indeed, using either endogenous
creatinine clearance44 or [51Cr] EDTA clearance,45–47 some
investigators have reported small increases in GFR together
with either no change or an increase in renal plasma flow
during the luteal phase, whereas others found no
change.30,31,44–48 In another study, investigators have as-
sessed the renal and peripheral hemodynamic responses to
angiotensin II receptor blockade with losartan during the two
phases of the menstrual cycle in subjects receiving a fixed
sodium diet containing 150 mmol/day.49 In this study,
despite an apparent activation of the renin-angiotensin system
during the luteal phase, a comparable renal vasodilatation
during angiotensin II blockade was observed during the two
phases of the menstrual cycle.49
In our normotensive subjects studied either during the
follicular or during the luteal phase of their menstrual
cycle, GFR and renal plasma flow were similar in the two
phases of the cycle when subjects were studied while
receiving a low sodium intake.35 However, whereas salt
loading had no effect on renal hemodynamics in the fol-
licular phase, the administration of salt during the luteal
phase induced a marked renal vasodilation with no change
in GFR (Fig. 2). Hence, a significant decrease in filtration
fraction was observed while receiving high salt during the
luteal but not during the follicular phase.35 Plasma renin
activity (PRA) and aldosterone levels decrease signifi-
cantly after sodium loading in the two phases of themenstrual cycle. Yet, the salt-induced suppression of PRA
is partly blunted in the luteal compared with the follicular
phase.35
Thus, our data suggest that in contrast to arterial pres-
sure, the control of the renal circulation is salt sensitive
during the luteal phase of the menstrual cycle and that
endogenous female sex hormones act in a direct or indirect
way on glomerular hemodynamics with a possible effect
on the efferent arteriole, inasmuch as the filtration fraction
decreases upon salt loading. By comparison, the renal
hemodynamic response to salt in young normotensive
male subjects is characterized by an increase in renal
plasma flow and a concomitant rise in GFR, which was not
observed in women studied in the luteal phase.50 To ex-
plain the salt-induced renal vasodilatation and fall in fil-
tration fraction in women studied during the luteal phase,
we propose the hypothesis that estrogens modulate the
renal hemodynamics indirectly via the nitric oxide (NO)
pathway and perhaps prostaglandin formation, thereby
inhibiting the effects of angiotensin II on glomerular he-
modynamics. Indeed, estrogen levels are high in the luteal
phase, and estradiol has been shown to increase local
prostaglandin E2 (PGE2) and I2 (PGI2) production and to
activate NO synthase.51,52 Because NO has been proposed
as a physiologic antagonist of angiotensin II53 and because
blockade of endothelium-derived NO synthesis has been
shown to increase intraglomerular BP,54,55 female sex
hormones could modulate indirectly, via the NO pathway,
and perhaps prostaglandin synthesis, the effect of angio-
tensin II on glomerular hemodynamics and particularly on
efferent arteriolar tone. Through this mechanism, estro-
gens could cause renal vasodilation and a decrease in
filtration fraction.
There are few data on the renal hemodynamic effects of
OC.19,55–57 An early study by Hollenberg et al has shown
FIG. 2. Salt-induced variations in glomerular filtration rate (GFR)
and effective renal plasma flow (ERPF) in normotensive women
during the normal menstrual cycle, with the use of oral contracep-
tives, and after the menopause. HS  high-sodium diet; LS  low-
sodium diet. #P  .05 LS versus HS.that OC in healthy young women reduces the effective
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activation of the renin-angiotensin system by OC.19 The
administration of OC has also been found to increase
creatinine clearance in young women studied while receiv-
ing a free sodium intake.57 Kang et al reported significant
increases in systolic BP, renal vascular resistance, and
filtration fraction in OC users compared with nonusers and
showed that these differences were at least partially abol-
ished by angiotensin II blockade.58 Based on their data, the
authors have suggested that despite humoral evidence of
renin angiotensin system activation by OC, the tissue
response may actually be down-regulated, perhaps at a
receptor level. In a more recent study, Ribstein et al failed
to confirm that the renin-angiotensin system plays a prom-
inent role in maintaining a high BP in women with OC-
associated hypertension.56
In our normotensive women, OC had a marked influ-
ence on the renal hemodynamic response to salt, although
systemic BP was not affected34 (Fig. 2). Indeed, upon salt
loading, GFR increased significantly in women taking OC,
whereas renal plasma flow was unchanged; consequently,
filtration fraction was significantly increased, suggesting
an increased intraglomerular pressure. Importantly,
plasma renin activity in our OC users was several-fold
higher than the activity measured in OC nonusers studied
at comparable levels of salt intake. Therefore, the mech-
anism resulting in the salt-induced increase in GFR in OC
users may actually be the same as the one that we hypoth-
esize to occur during the luteal phase of the menstrual
cycle but with one important difference: namely, the base-
line activity of the renin-angiotensin system. Thus, in OC
users, the vasodilatory effect of estrogens may be more
prominent at the level of the afferent arteriole, thereby
leading to an increase in GFR and filtration fraction. An
alternative explanation for the apparent difference between
endogenous and exogenous female sex hormones, as re-
flected by the more pronounced effect of salt loading on
renal hemodynamic in OC users than in nonusers, is per-
haps a difference in potency between endogenous and
exogenous female sex hormones. Indeed, combined OC
agents deliver pharmacologic levels of estrogens that ex-
hibit six to 10 times the estrogenic activity provided by
endogenous estrogens.59
Several investigators have found that sodium induces a
renal vasoconstriction in salt-sensitive patients.60 We
found a similar pattern, with a salt-induced reduction in
renal plasma flow and an increase filtration fraction, in
our group of salt-sensitive normotensive menopausal
women.38 This maladaptive response to a sodium load
may be attributed to a lack of estrogens leading again to a
reduced capacity of the renal circulation to vasodilate. An
endothelial dysfunction has frequently been observed after
the menopause, with an impaired systemic endothelium-
dependent relaxation. In addition, it is also known that
PRA is higher in post-menopasual than in pre-menopausal
women. In our evaluation of normotensive menopausal
women, suppression of PRA is blunted after salt loading.At the time of menopause, in addition to aging and to-
gether with the loss of estradiol (which is known to de-
crease renin release), this poor suppression of renin by salt
could contribute to the development of salt-sensitive hy-
pertension in elderly women and may reflect an interaction
between the renin system and menopausal status.
Altogether, our results demonstrate that endogenous as
well as exogenous female sex hormones strongly affect the
renal hemodynamic response to salt in young normoten-
sive women, although these hormones do not affect the BP
response to sodium.
Female Sex Hormones
and Renal Sodium Handling
The menstrual cycle as well as the menopause are char-
acterized by great variations in plasma progesterone, es-
trogen, aldosterone, and plasma renin activity—hormonal
systems that are known to modulate the renal tubular
handling of sodium either in the proximal or in the distal
nephrons. In addition, androgen receptors have been lo-
calized in the proximal tubule segment of the nephron,
suggesting that testosterone could also affect renal sodium
reabsorption.61 So far, several studies have examined the
effects of female sex hormones on the overall 24-h sodium
excretion.62–67 The results of these studies are often con-
tradictory, perhaps because most studies were conducted
in subjects ingesting uncontrolled amounts of sodium or
because subjects were receiving large amounts of water to
measure renal function, which is an important confound-
ing factor interacting with renal sodium handling.50 None
of these studies have really attempted to analyze in more
detail the respective changes in proximal and distal so-
dium reabsorption occurring either during the normal
menstrual cycle or with the administration of OC.
In the past few years, we have used the endogenous
lithium clearance technique to investigate the respective
changes in proximal and post-proximal tubular sodium reab-
sorption to investigate the tubular adaptation occurring with
large changes in sodium intake in normotensive as well as
hypertensive individuals.50,68,69 This technique is currently
considered to be the most reliable approach to investigate
proximal segmental renal sodium handling in humans. When
young normotensive men are shifted from a low-salt to a
high-salt diet, the lithium clearance increases significantly
and the fractional distal reabsorption of sodium decreases,
indicating that both the proximal and the distal reabsorptions
of sodium are reduced to maintain sodium balance.50
Similar investigations were conducted in our normo-
tensive women, and significant differences in tubular re-
sponses were observed between the follicular and the
luteal phases.36 In the follicular phase, the renal tubular
response to a sustained increase in sodium intake is com-
parable to that in men. In contrast, during the luteal phase,
increasing sodium intake leads to a marked sodium escape
from the distal nephron and no change in proximal sodium
reabsorption, suggesting that while maintaining a diet high
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distal segments of the nephron with a paradoxical increase
in sodium reabsorption in the proximal nephron. Thus, the
relationship between the proximal reabsorption of sodium
as measured by the fractional excretion of lithium (FELi)
and the overall fractional excretion of sodium (FENa) is flat
and significantly different from that in women studied in
the follicular phase (Fig. 3). The finding of significantly
reduced sodium reabsorption in the distal nephron in the
luteal phase when consuming a high-salt diet may reflect
the pivotal role of progesterone to act as an anti-aldoste-
rone compound and to participate in the maintenance of
sodium balance during the pre-menstrual phase. This ef-
fect of progesterone is particularly demonstrable with a
high-salt diet when circulating aldosterone levels are
low.36 The increased reabsorption of sodium in the prox-
imal tubule with a high-salt diet is more surprising. Al-
though one cannot exclude a direct tubular effect of
progesterone to stimulate proximal sodium reabsorption,
possibly in relation with the renal vasodilation, we believe
that the low lithium clearance represents a compensatory
mechanism of the proximal tubule to avoid an excessive
loss of sodium by the distal nephron, thereby preventing
sodium wasting and maintaining sodium balance. The
increase in proximal sodium reabsorption may actually
provide a clue for the blunted salt-induced decrease in
plasma renin activity observed in the luteal phase com-
pared with the follicular phase as discussed earlier here.
Indeed, as sodium reabsorption is enhanced in the proxi-
mal segments of the nephron, the delivery of sodium to the
macula densa is reduced. A decreased sodium delivery at
the juxta-glomerular apparatus will stimulate renin secre-
tion. In turn, the increased PRA and angiotensin II further
enhance the sodium reabsorption by the proximal nephron.
Endogenous progesterone is known to be natriuretic,
FIG. 3. Relationship between the fractional excretion of endoge-
nous lithium (FELi), an index of the amount of sodium coming out of
the proximal tubule, and the fractional excretion of sodium (FENa),
the expression of the overall sodium excretion. In the luteal phase,
we observed a marked sodium escape from the distal nephron com-
pared with the follicular phase and with OC users on a high-salt diet,
indicating that sodium balance is controlled mainly by the distal
segments of the tubule with a paradoxical proximal increase in
sodium reabsorption.but synthetic derivatives of progesterone may lack natri-uretic properties, for they have decreased affinity for renal
mineralocorticoid receptors.70 In our young patients using
OC, the renal tubular handling of sodium was similar to
that observed in normal women in the follicular phase.
However, the FELi /FENarelationship is shifted to lower
levels of FELi (Fig. 3). This shift may be attributed to the
activation of the renin-angiotensin system by OC, leading
to an increased proximal reabsorption of sodium. A high
reabsorption of sodium was also found to occur in the
distal tubule as reflected by the very high distal reabsorp-
tion of sodium. Thus, combined OC do not appear to affect
the balance between the proximal and the distal nephron
segments. However, because of the activation of the renin-
angiotensin system, women using OC may have a greater
tubular responsiveness.
Effect of Sodium Loading
on Body Weight in Women
Despite the common belief that women gain weight pre-
menstrually because of sodium retention, there is little
convincing evidence that sodium and water retention in-
deed occur during the luteal phase of a normal menstrual
cycle.62–67 We found that under carefully controlled so-
dium diets, a high sodium intake induces a weight gain of
the same magnitude in the follicular and the luteal phase of
the cycle (1.0 kg), showing that no systematic sodium
retention occurs in the luteal phase of the normal men-
strual cycle (Fig. 4). This observation was based on weight
determination, which of course provides no information on
water redistribution within the body. The results suggest
that the symptoms of edema and bloating reported by
some women in the second phase of the cycle may be due
to either a redistribution of fluid from the intravascular
into the interstitial compartment rather than to sodium
retention or to increased sodium appetite during the luteal
phase of the menstrual cycle.71,72 When the diet is
changed from a low-salt to a high-salt diet, the weight gain
is comparable in women using OC. However, the weight
gain is significantly more marked in menopausal women
(2.5 kg for comparable changes in sodium intake). Mul-
FIG. 4. Changes in body weight measured in normotensive women
during the normal menstrual cycle, under oral contraceptives and
after the menopause when going from a low to a high salt intake.
*P  .05 menopause versus other groups.
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induced change in body weight was a strong determinant
of the change in BP (P  .03; 95% confidence interval
0.10 to 2.28).
Conclusion
In conclusion, endogenous and exogenous sex female hor-
mones profoundly influence systemic and renal response to
salt in women. Our data show that the BP of young normo-
tensive women, regardless of whether they are using contra-
ceptives, is rather insensitive to salt, with a normal pattern of
adaptation of renal proximal and distal reabsorption to chang-
ing salt intake. In contrast, women become salt sensitive after
menopause. In contrast to the systemic pressure, the renal
hemodynamic response to salt is modulated by female sex
hormones. These hormones also affect the regulation of so-
dium excretion. These recent observations provide new in-
sights into potential mechanisms explaining the lower
incidence of cardiovascular disease and the lower rate of
progression of renal disease in pre-menopausal women,
which tend to disappear with menopause. They also empha-
size the importance of considering more carefully the phase
of the menstrual cycle whenever conducting physiologic and
pharmacologic studies in pre-menopausal women and when
enrolling women in clinical studies, to prevent the strong
influence of progesterone and high levels of estrogens on
renal and systemic parameters. The increased salt sensitivity
in menopausal women strongly encourages the use of diuret-
ics in hypertensive women, which is in agreement with recent
hypertension guidelines.
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